Molecular analysis of a Myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers

Japanese Journal of Cancer Research

Volumn 89, Issue 4, 1998, Pages 347-351

  Takahashi, Takao ^a,b   Konishi, Hiroyuki ^a   Kozaki, Ken Ichi ^a   Osada, Hirotaka ^a   Saji, Shigetoyo ^b   Takahashi, Toshitada ^a   Takahashi, Takashi ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b GIFU UNIVERSITY   (Japan)

Author keywords

17p13.3; Lung cancer; Mnt; ROX

Indexed keywords

PROTEIN P53;

ARTICLE; CENTROMERE; CHROMOSOME 17P; GENE DELETION; HUMAN; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MOLECULAR BIOLOGY; ONCOGENE MYC; PATHOGENESIS; PRIORITY JOURNAL; TELOMERE; TUMOR SUPPRESSOR GENE;

EID: 0031959321     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb00569.x     Document Type: Article

References (29)

1. Minna, J. D., Sekido, Y., Fong, K. M. and Gazdar, A. F. Cancer of the lung. In "Cancer Principles & Practice of Oncology," ed. V. T. DeVita, S. Hellman and S. A. Rosenberg, pp. 849-949 (1997). Lippincott-Raven. Philadelphia.
2. Kamb, A., Gruis, N. A. Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., III, Johnson, B. E. and Stolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440 (1994).
3. Washimi, O., Nagatake, M., Osada, H., Ueda, R., Koshikawa, T., Seki, T., Takahashi, T. and Takahashi, T. In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in non-small cell lung cancers. Cancer Res., 55, 514-517 (1995).
4. Harbour, J. W., Lai, S. L., Whang-Peng, J., Gazdar, A. F., Minna, J. D. and Kaye, F. J. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science, 241, 353-357 (1988).
5. Takahashi, T., Nau, M. M., Chiba, I., Birrer, M. J., Rosenberg, R. K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A. F. and Minna, J. D. p53: a frequent target for genetic abnormalities in lung cancer. Science, 246, 491-494 (1989).
6. Nagatake, M., Takagi, Y., Osada, H., Uchida, K., Mitsudomi, T., Saji, S., Shimokata, K., Takahashi, T. and Takahashi, T. Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res., 56. 2718-2720 (1996).
7. Uchida, K., Nagatake, M., Osada, H., Yatabe, Y., Kondo, M., Mitsudomi, T., Masuda, A., Takahashi, T. and Takahashi T. Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers. Cancer Res., 56, 5583-5585 (1996).
8. Yokota, J., Wada, M., Shimosato, Y., Terada, M. and Sugimura, T. Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. USA, 84, 9252-9256 (1987).
9. Meroni, G., Reymond, A., Alcalay, M., Borsani, G., Tanigami, A., Tonlorenzi, R., Nigro, C. L., Messali, S., Zollo, M., Ledbetter, D. H., Brent, R., Ballabio, A. and Carrozzo, R. Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor. EMBO J., 16, 2892-2906 (1997).
10. Hurlin, P. J., Queva, C. and Eisenman, R. N. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Dev., 11, 44-58 (1997).
11. Blackwood, E. M. and Eisenman, R. N. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science, 251, 1211-1217 (1991).
12. Ayer, D. E., Kretzner, L. and Eisenman, R. N. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell, 12, 211-222 (1993).
13. Zervos, A. S., Gyuris, J. and Brent, R. Mxil, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell, 12, 223-232 (1993).
14. Hurlin, P. J., Queva, C., Koskinen, P. J., Steingrimsson, E., Ayer, D. E., Copeland, N. G., Jenkins, N. A. and Eisenman, R. N. Mad3 and Mad4: novel Max-interacting transcriplional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J., 14, 5646-5659 (1995).
15. Chen, J., Willingham, T., Margraf, L. R., Schreiber-Agus, N., DePinho, R. A. and Nisen, P. D. Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells. Nat. Med., 1, 638-643 (1995).
16. Eagle, L. R., Yin, X., Brothman, A. R., Williams, B. J., Atkin, N. B. and Prochownik, E. V. Mutation of the MXI1 gene in prostate cancer. Nat. Genet., 9, 249-255 (1995).
17. Carrozzo, R. and Ledbetter, D. H. Dinucleotide repeat polymorphism mapping to the critical region for lissencephaly (17p13.3). Hum. Mol. Genet., 2, 615 (1993).
18. Hibi, K., Yamakawa, K., Ueda, R., Horio, Y., Murata, Y., Tamari, M., Uchida, K., Takahashi, T., Nakamura, Y. and Takahashi, T. Aberrant upregulalion of a novel integrin α subunit gene at 3p21.3 in small cell lung cancer. Oncogene, 9, 611-619 (1994).
19. Petersen, S., Wolf, G., Bockmühl, U., Gellert, K., Dietel, M. and Petersen, I. Allelic loss on chromosome 10q in human lung cancer: association with tumour progression and metastatic phenotype. Br. J. Cancer, 77, 270-276 (1998).
20. Hibi, K., Takahashi, T., Yamakawa, K., Ueda, R., Sekido, Y., Ariyoshi, Y., Suyama, M., Takagi, H., Nakamura, Y. and Takahashi, T. Three distinct regions involved in 3p deletion in human lung cancer. Oncogene, 7, 445-449 (1992).
21. Chung, G. T., Sundaresan, V., Hasleton, P., Rudd, R., Taylor, R. and Rabbitts, P. H. Sequential molecular genetic changes in lung cancer development. Oncogene, 11, 2591-2598 (1995).
22. Coles, C., Thompson, A. M., Elder, P. A., Cohen, B. B., Mackenzie, I. M., Cranston, G., Chetty, U., Mackay, J., Macdonald, M., Nakamura, Y., Hoyheim, B. and Steel, C. M. Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet. 336, 761-763 (1990).
23. Sato, T., Tanigami, A., Yamakawa, K., Akiyama, F., Kasumi, F., Sakamoto, G. and Nakamura, Y. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res., 50, 7184-7189 (1990).
24. Phillips, N. J., Ziegler, M. R., Radford, D. M., Fair, K. L., Steinbrueck, T., Xynos, F. P. and Donis-Keller, H. Allelic deletion on chromosome 17p13.3 in early ovarian cancer. Cancer Res., 56, 606-611 (1996).
25. Biegel, J. A., Burk, C. D., Barr, F. G. and Emanuel. B. S. Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors. Cancer Res., 52, 3391-3395 (1992).
26. Cogen, P. H., Daneshvar, L., Metzger, A. K., Duyk, G., Edwards, M. S. and Sheffield, V. C. Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis. Am. J. Hum. Genet., 50, 584-589 (1992).
27. Saxena, A., Clark, W. C., Robertson, J. T., Ikejiri, B., Oldfield, E. H. and Ali, I. U. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas. Cancer Res., 52, 6716-6721 (1992).
28. Fujimori, M., Tokino, T., Hino, O., Kitagawa, T., Imamura, T., Okamoto, E., Mitsunobu, M., Ishikawa, T., Nakagama, H., Harada, H., Yagura, M., Matsubara, K. and Nakamura, Y. Allelotype study of primary hepatocellular carcinoma. Cancer Res., 51, 89-93 (1991).
29. Park, S. Y., Kang, Y. S., Kim, B. G., Lee, S. H., Lee, E. D., Lee. K. H., Park, K. B. and Lee, J. H. Loss of heterozygosity on the short arm of chromosome 17 in uterine cervical carcinomas. Cancer Genet. Cytogenel., 79, 74-78 (1995).